ALOI, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 5.561
EU - Europa 1.647
AS - Asia 1.009
SA - Sud America 17
AF - Africa 16
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.259
Nazione #
US - Stati Uniti d'America 5.463
IT - Italia 641
SG - Singapore 394
IN - India 315
CN - Cina 244
SE - Svezia 210
RO - Romania 205
IE - Irlanda 173
FI - Finlandia 116
DE - Germania 77
UA - Ucraina 65
CA - Canada 54
RU - Federazione Russa 46
BZ - Belize 33
GB - Regno Unito 26
BG - Bulgaria 24
NL - Olanda 19
ID - Indonesia 18
BE - Belgio 12
MX - Messico 10
TR - Turchia 9
PK - Pakistan 8
AR - Argentina 7
FR - Francia 7
TG - Togo 7
BR - Brasile 6
MY - Malesia 6
DK - Danimarca 5
PL - Polonia 5
ZA - Sudafrica 5
AU - Australia 4
CL - Cile 4
CZ - Repubblica Ceca 4
EU - Europa 4
LT - Lituania 3
AT - Austria 2
ES - Italia 2
IL - Israele 2
JP - Giappone 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CR - Costa Rica 1
EG - Egitto 1
HK - Hong Kong 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 8.259
Città #
Fairfield 895
Woodbridge 441
Ashburn 440
Chandler 404
Seattle 381
Cambridge 315
Houston 315
Wilmington 295
Singapore 278
Rome 269
Ann Arbor 221
Horia 186
Dublin 173
Beijing 152
Princeton 143
San Paolo di Civitate 111
Santa Clara 107
San Jose 95
Plano 85
Lawrence 76
San Diego 69
New York 67
Millbury 62
Boston 48
Dearborn 41
Belize City 33
Buffalo 32
Norwalk 31
Des Moines 30
Andover 28
Milan 28
Helsinki 27
Ottawa 26
Sofia 24
Las Vegas 23
Saint Louis 23
Toronto 22
Moscow 19
Albuquerque 17
Jakarta 17
Lappeenranta 17
Falkenstein 15
Stockholm 15
Nanjing 14
Jacksonville 13
Naples 12
Bühl 11
Brussels 10
San Mateo 10
Falls Church 9
Guangzhou 9
Kunming 9
Los Angeles 9
Bremen 8
Chicago 8
Columbus 8
Hefei 8
Federal 7
Lomé 7
Mannheim 7
Mexico City 7
Southend 7
Acquaviva delle Fonti 6
Boardman 6
Frankfurt am Main 6
Amsterdam 5
Capranica 5
Dallas 5
Florence 5
Pune 5
Bologna 4
Changsha 4
Civitanova Marche 4
Islamabad 4
Istanbul 4
Lecce 4
Montréal 4
Multan 4
Prague 4
Redmond 4
Shenyang 4
Ankara 3
Chengdu 3
Fremont 3
Grafing 3
Hyderabad 3
Libertyville 3
London 3
Lucera 3
Mcallen 3
Monza 3
Phoenix 3
Porto Alegre 3
Provo 3
Taranto 3
Trento 3
Trumbull 3
Verona 3
Viterbo 3
Washington 3
Totale 6.413
Nome #
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features 189
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease 168
705 A Prospective 24-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn Disease as Detected by Colon Capsule Endoscopy 128
Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: efficacy of infliximab as a rescue therapy 116
Prospective evaluation of the achievement of mucosal healing with anti-TNF-α therapy in a paediatric Crohn's disease cohort 115
A Prospective 52-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn's Disease as Detected by Colon Capsule Endoscopy 115
A prospective 24-week mucosal healing and deep-remission assessment of small bowel and colonic Crohn's disease as detected by colon capsule endoscopy 103
Gelatin tannate for acute childhood gastroenteritis: a randomized, single-blind controlled trial 100
A prospective 52-week mucosal healing and deep remission assessment of small bowel and colonic Crohn’s disease as detected by colon capsule endoscopy 98
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 98
Advances in the medical management of paediatric IBD 96
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation 93
Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease 93
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease 93
Argon plasma coagulator in a 2-month-old child with tracheoesophageal fistula 90
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease 89
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis 87
Intestinal lymphoid nodular hyperplasioa in children. the relationship to food allergy 87
Predictors of long-term clinical and endoscopic remission in children with crohn disease treated with infliximab 87
Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation 86
Small intestine contrast ultrasonography in pediatric Crohn's disease. 86
Premature Subclinical Atherosclerosis in Pediatric Inflammatory Bowel Disease 84
Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease 84
A promising medium-term follow-up of pediatric sclerosing cholangitis. Mild phenotype or early diagnosis 82
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release 81
Intestinal inflammation alters the expression of hepatic bile acid receptors causing liver impairment 80
Altered Coagulation in Pediatric Inflammatory Bowel Disease: Role on Inherited and Acquired Risk Factors 79
First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease 79
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: A randomized, double-blind, placebo controlled trial 79
Natural history of pancreatic involvement in paediatric inflammatory bowel disease 78
Pneumatic Balloon Dilation in Pediatric Achalasia: Efficacy and Factors Predicting Outcome At a Single Tertiary Pediatric Gastroenterology Center 78
Human herpes virus-6 chromosomal integration misled the management of Crohn's disease. 77
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice 77
Autoimmune Enteropathy in a 13-Year-Old Celiac Girl Successfully Treated With Infliximab 77
Premature Subclinical Atherosclerosis in Pediatric Inflammatory Bowel Disease 77
Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease 76
Capsule endoscopy followed by single balloon enteroscopy in children with obscure gastrointestinal bleeding. A combined approach 76
Bowel preparations for colonoscopy: An RCT 75
Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre. 75
Usefulness of single-balloon enteroscopy in pediatric Crohn's disease 74
Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn's disease 74
Atopic manifestations in children born preterm: a long-term observational study 74
Role of Gastroesophageal Reflux in Children With Unexplained Chronic Cough 73
Presenting features and disease course of pediatric ulcerative colitis. 72
Gut microbiota and pediatric disease 71
Early Versus Late Immunomodulatory Therapy in Pediatric CD: A Prospective Observational Study in a Tertiary Referral Center 71
Role of Methotrexate in Pediatric Ulcerative Colitis 70
Validating the Role of Necroptosis in Inflammatory Bowel Disease (IBD) Pathogenesis 70
Investigation of small bowel in pediatric Crohn's disease 69
Interactions Between Intestinal Microbiota and Innate Immune System in Pediatric Inflammatory Bowel Disease 69
European Crohn's and Colitis Organisation topical review on transitional care in inflammatory bowel disease 69
Modern imaging of Crohn’s disease: a comparison of wireless capsule endoscopy and small intestine contrast ultrasonography(SICUS) in paediatric patients. Dig Liv Dis 2008, 40:CO2 69
Short-term response to adalimumab in children with inflammatory bowel disease 69
Obese patients with a binge eating disorder have an unfavorable metabolic and inflammatory profile 67
Phenotype and disease course of early-onset pediatric inflammatory bowel disease 67
Outcome of Biological Therapy in Pediatric Inflammatory Bowel Disease at a Single Tertiary Center 66
Ultrasonography of the Colon in Pediatric Ulcerative Colitis: A Prospective, Blind, Comparative Study with Colonoscopy 66
Mapping histologic patchiness of celiac disease by push enteroscopy 65
Clinical Trials (Clinician Perspective) 64
Second-generation colon capsule endoscopy vs. colonoscopy in pediatric ulcerative colitis: a pilot study. 64
Mapping histologic patchiness of Celiac Disease by Push Enteroscopy” 62
Usefulness of Single Balloon Enteroscopy in Pediatric Crohn's Disease 61
Mapping Histologic Patchiness of Celiac Disease by Push Enteroscopy 59
CEACAM6: A Possible Role in Pediatric Crohn's Disease? 58
Narrow band imaging combined with water immersion technique in the diagnosis of celiac disease 58
Non-acid gastro-oesophageal reflux in children with suspected pulmonary aspiration 58
Transcription factor ZNF281: a novel player in intestinal inflammation and fibrosis 58
Diagnostic accuracy of multimodal noninvasive follow-up for pediatric ulcerative colitis: A single-center prospective study 56
null 55
Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: the Italian society of pediatric gastroenterology, hepatology, and nutrition experience 55
Long-term effects on growth of an energy-enhanced parenteral nutrition in preterm newborn: a quasi-experimental study 53
null 52
Mucosal healing in Crohn's disease: new insights 52
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 52
Corrigendum to: Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study 52
Predicting outcomes in pediatric Crohn's disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease–ahead program 52
Predicting the durability of biological therapy in pediatric Crohn's disease: do the immunomodulators matter? 50
Activated Rip2 kinase is overexpressed in the intestinal mucosa of adult and pediatric inflammatory bowel disease patients and may represent a novel therapeutic target. 49
null 47
null 47
Biological therapy In a Pediatric Crohn's disease population followed at a referral center 46
null 45
In children eradication of Helicobacter pilori does not promote gastro-oesophageal reflux disease: a multichannel Ph-impedance study. Dig Liv Dis 2006, 38: PA28 44
null 44
null 44
Short-Term Efficacy and Safety of Adalimumab in Children with Active Crohn's Disease: A Prospective, Open Label, Single Center Trial 43
null 43
Apparato Digerente 42
null 42
Aortic and intima media thickness in children with IBD 41
null 41
null 41
null 41
A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn's Disease 41
null 41
Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn's disease: a prospective, blinded, comparison study 40
Manifestazioni cutanee in corso di terapia con anti TNF in pazienti pediatrici con malattie infiammatorie intestinali 39
null 39
null 38
null 38
Totale 7.003
Categoria #
all - tutte 26.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.343 0 0 0 0 0 0 388 288 257 214 122 74
2020/20211.108 171 77 28 221 17 21 60 73 152 70 125 93
2021/20221.498 11 58 158 39 250 82 44 136 139 82 217 282
2022/20231.528 271 271 84 144 131 158 33 97 247 20 43 29
2023/2024795 55 86 31 44 66 120 34 51 13 120 86 89
2024/2025703 67 72 120 66 189 154 35 0 0 0 0 0
Totale 8.751